Abstract | INTRODUCTION: RESULTS: CONCLUSIONS:
Tacrolimus shows a beneficial effect on CAD; this could be attributed to the fact that CAD is characterized by a lymphohistiocytic infiltrate producing a chronic eczema and that tacrolimus blocks the activation of lymphocytes and other immune system cells, also inhibiting the release of mediators from cutaneous mast cells and basophils.
|
Authors | A Baldo, E Prizio, G Mansueto, P Somma, G Monfrecola |
Journal | The Journal of dermatological treatment
(J Dermatolog Treat)
Vol. 16
Issue 4
Pg. 245-8
( 2005)
ISSN: 0954-6634 [Print] England |
PMID | 16249148
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Immunosuppressive Agents
- Ointments
- Tacrolimus
|
Topics |
- Administration, Topical
- Humans
- Immunosuppressive Agents
(administration & dosage)
- Male
- Middle Aged
- Ointments
- Photosensitivity Disorders
(drug therapy, pathology)
- Skin
(pathology)
- Tacrolimus
(administration & dosage)
|